Form 4: Marchex Inc. CEO Edwin A. Miller Receives Stock Option Awards

Edwin A. Miller, CEO of Marchex Inc., was granted stock options on July 26, 2024, including options that vest over four years and options that vest in full on the fourth anniversary.

Summary

• Edwin A. Miller, the CEO of Marchex Inc., filed a Form 4 with the SEC on July 29, 2024.
• The filing reports the grant of two employee stock option awards on July 26, 2024.
• The first option grants the right to buy 250,000 shares of Class B Common Stock at an exercise price of $1.58 per share, vesting over four years.
• 25% of these shares vest on the first anniversary of the grant date, with the remainder vesting quarterly over the subsequent three years.
• The second option grants the right to buy 150,000 shares of Class B Common Stock at an exercise price of $1.58 per share, vesting in full on the fourth anniversary of the grant date.
• Both options are subject to acceleration of vesting in certain events and expire on July 26, 2034.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock option grants, which is a common practice. The vesting schedule suggests a long-term incentive for the CEO.

Positives

• The granting of stock options to the CEO can align his interests with those of the shareholders, incentivizing him to increase the company's value.
• The vesting schedules encourage long-term commitment from the CEO.

Industry Context

Stock options are a common form of executive compensation used to incentivize performance and align management's interests with those of shareholders. The specific terms of the options, such as the vesting schedule and exercise price, are typical for such arrangements.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the tech industry, often used by companies like Marchex to attract and retain top talent.
• Vesting schedules, such as the four-year vesting period described in the document, are common in the industry to ensure long-term commitment from executives.
• The exercise price of $1.58 is relevant in the context of Marchex's current stock price and historical performance, and would need to be compared to similar companies to assess its competitiveness.

Stakeholder Impact

• Shareholders: The stock option grants could potentially dilute existing shareholders if the options are exercised.
• Employees: The grant could have a positive impact on employee morale as it shows the company is investing in its leadership.

Key Dates